Insulin resistance and not steatosis is associated with modifications in oxidative stress markers in chronic hepatitis C, non-3 genotype

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Free radical research

• Publication date

  2009-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/10715760903247249PMID 19905981
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin Resistance in Chronic Hepatitis C: Association with Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis

  2008cited by this paper
• Hepatic steatosis: a benign disease or a silent killer.

  2008cited by this paper
• Prospective study of liver transplant recipients with HCV infection: Evidence for a causal relationship between HCV and insulin resistance

  2008cited by this paper
• Evidence of oxidative stress as a cofactor in the development of insulin resistance in patients with chronic hepatitis C

  2008cited by this paper
• Genotype‐specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C

  2008cited by this paper
• Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.

  2008cited by this paper
• Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C.

  2008cited by this paper
• Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis

  2006cited by this paper
• Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy

  2006cited by this paper
• Blood oxidative stress markers are unreliable markers of hepatic steatosis

  2006cited by this paper
• Impact of obesity on treatment of chronic hepatitis C

  2006cited by this paper
• Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients

  2005cited by this paper
• In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C: correlation with hepatic steatosis

  2005cited by this paper
• Hepatitis C Virus Core Protein Inhibits Mitochondrial Electron Transport and Increases Reactive Oxygen Species (ROS) Production*

  2005cited by this paper
• Insulin Resistance Plays a Significant Role in Liver Fibrosis in Chronic Hepatitis C and in the Response to Antiviral Therapy

  2005cited by this paper
• Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients.

  2005cited by this paper
• Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

  2005cited by this paper
• Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease.

  2004cited by this paper
• 501 LB84318, a novel and small-molecular caspase inhibitor, potently protects hepatic damage in mouse models of liver injury

  2004cited by this paper
• Role of β 2-Glycoprotein I, LDL-, and Antioxidant Levels in Hypercholesterolemic Elderly Subjects

  2004cited by this paper
• Steatosis affects chronic hepatitis C progression in a genotype specific way

  2004cited by this paper
• Aging and oxidative stress.

  2004cited by this paper
• Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States.

  2004cited by this paper
• Effect of treatment with peginterferon or interferon alfa‐2b and ribavirin on steatosis in patients infected with hepatitis C

  2003cited by this paper
• Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome

  2003cited by this paper
• Impaired IRS‐1/PI3‐kinase signaling in patients with HCV: A mechanism for increased prevalence of type 2 diabetes

  2003cited by this paper
• Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression

  2003cited by this paper
• Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

  2003cited by this paper
• Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

  2003cited by this paper
• Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein.

  2002cited by this paper
• Oxidative stress in chronic hepatitis C: not just a feature of late stage disease.

  2002cited by this paper
• Serum and liver micronutrient antioxidants and serum oxidative stress in patients with chronic hepatitis C

  2002cited by this paper
• Oxidative stress-related molecules and liver fibrosis.

  2001cited by this paper
• Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C.

  2001cited by this paper
• Etiopathogenesis of Nonalcoholic Steatohepatitis

  2001cited by this paper
• Oxidative stress in symptom‐free HCV carriers: relation with ALT flare‐up

  2001cited by this paper
• Nonalcoholic Steatohepatitis: Definition and Pathology

  2001cited by this paper
• Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C

  2000cited by this paper
• Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection.

  2000cited by this paper
• Prevalence of Type 2 Diabetes Mellitus among Persons with Hepatitis C Virus Infection in the United States

  2000cited by this paper
• Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.

  2000cited by this paper
• Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

  1999cited by this paper
• Antioxidant status and glutathione metabolism in peripheral blood mononuclear cells from patients with chronic hepatitis C.

  1999cited by this paper
• Fibrogenic effect of oxidative stress on rat hepatic stellate cells

  1998cited by this paper
• Steatohepatitis: a tale of two "hits"?

  1998cited by this paper
• Protein carbonyl measurement by a sensitive ELISA method.

  1997cited by this paper
• Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.

  1997cited by this paper
• An algorithm for the grading of activity in chronic hepatitis C

  1996cited by this paper
• High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case-control study.

  1996cited by this paper
• Association between reactive oxygen species and disease activity in chronic hepatitis C.

  1996cited by this paper
• Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression.

  1995cited by this paper
• Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population.

  1994cited by this paper
• Role of glucose and insulin resistance in development of type 2 diabetes mellitus.

  1992cited by this paper
• Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study.

  1992cited by this paper
• Intravenous immunoglobulin for multifocal motor neuropathy.

  1992cited by this paper
• Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.

  1990cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper
• Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues.

  1969cited by this paper

• Hyperferritinemia Has Multifactorial Etiology in Naive Patients with Chronic Hepatitis C

  2020cites this paper
• Increased lipid peroxidation and erythrocyte glutathione peroxidase activity of patients with type 2 diabetes mellitus: Implications for obesity and central obesity

  2019cites this paper
• Hepatitis C, systemic inflammation and oxidative stress: correlations with metabolic diseases

  2019cites this paper
• High prevalence of insulin resistance among Brazilian chronic hepatitis C patients

  2017cites this paper
• HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis

  2016cites this paper
• Insulin resistance and its consequences in chronic hepatitis C

  2015cites this paper
• Insulin resistance is associated with DNA damage in peripheral blood cells in non-diabetic patients with genotype 1 chronic hepatitis C

  2013cites this paper
• Association between insulin resistance and sustained virologic response in hepatitis C treatment, genotypes 1 versus 2 and 3: systematic literature review and meta-analysis

  2013cites this paper
• Oxidative stress is closely associated with insulin resistance in genotypes 1 and 3 chronic hepatitis C

  2013cites this paper
• HCV and Oxidative Stress in the Liver

  2013cites this paper
• Avaliação da resistência à insulina em pacientes com hepatite C crônica não diabéticos

  2013cites this paper
• Oxidative stress, endogenous antioxidants, alcohol, and hepatitis C: pathogenic interactions and therapeutic considerations.

  2012cites this paper
• Insulin resistance and chronic liver disease.

  2011cites this paper
• Hepatitis C virus, oxidative stress and steatosis: current status and perspectives.

  2011cites this paper
• Insulin resistance and hepatitis C: an evolving story

  2011influential citation
• Blood Glutathione Peroxidase Activity in Relation with the Risk of Cardiovascular Diseases in Obese Women

  2011cites this paper
• GUTJNL228262 1139..1151

  year unknowninfluential citation